Patients Views & Analysis

Views & Analysis

Patients

The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.

Patients

Is patient-centred trial design becoming a strategic advantage for mid-size pharma, helping cut risk, improve timelines, and engage patients?

Patients

Pharmaceutical manufacturers have begun, albeit tentatively, to acknowledge and respond to evolving dietary sensibilities.

Patients

NHS waiting lists are like fires that everyone is frantically trying to put out. But however much water we pour on it, the flames keep roaring.

Patients

During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.

Patients

Creating an environment where the patient is recognised as an active participant in their care journey is critical.